Long-Chain Omega-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer

REFERENCES

• Jemal A, Siegel R, Xu J, and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60, 277–300, 2010.
   PubMed Web of Science ®Google Scholar
• Cai Q, Gao YT, Chow WH, Shu XO, Yang G, et al.: Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. J Clin Oncol 24, 5010–5016, 2006.
   PubMed Web of Science ®Google Scholar
• Schottenfeld D and Beebe-Dimmer J: Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56(2), 69–83, 2006.
   PubMed Web of Science ®Google Scholar
• Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, Hoseini M, Parizade SM, et al.: Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol 64, 321–327, 2009.
   PubMed Web of Science ®Google Scholar
• Micallef MA and Garg ML: Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 204, 476–482, 2009.
   PubMed Web of Science ®Google Scholar
• Latham P, Lund EK, and Johnson IT: Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 20, 645–650, 1999.
   PubMed Web of Science ®Google Scholar
• Clarke RG, Lund EK, Latham P, Pinder AC, and Johnson IT: Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29. Lipids 34, 1287–1295, 1999.
   PubMed Web of Science ®Google Scholar
• Courtney ED, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, et al.: Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 22, 765–776, 2007.
   PubMed Web of Science ®Google Scholar
• Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, et al.: n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25, 2303–2310, 2004.
   PubMed Web of Science ®Google Scholar
• Wu S, Feng B, Li K, Zhu X, Liang S, et al.: Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Am J Med 125, 5519.e5, 2012.
   PubMed Web of Science ®Google Scholar
• Geelen A, Schouten JM, Kamphuis C, Stam BE, Burema J, et al.: Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. Am J Epidemiol 166, 1116–1125, 2007.
   PubMed Web of Science ®Google Scholar
• MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, et al.: Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295, 403–415, 2006.
   PubMed Web of Science ®Google Scholar
• Gerber M: Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr 107(Suppl 2), S228–S239, 2012.
   PubMedGoogle Scholar
• Wu CH, Wang CC, and Kennedy J: Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther 33, 1749–1758, 2011.
   PubMed Web of Science ®Google Scholar
• Satia JA, Littman A, Slatore CG, Galanko JA, and White E: Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study. Cancer Epidemiol Biomarkers Prev 18, 1419–1428, 2009.
   PubMed Web of Science ®Google Scholar
• White E, Patterson RE, Kristal AR, Thornquist M, King I, et al.: VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol. 159(1):83–93, 2004.
   PubMed Web of Science ®Google Scholar
• Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, et al.: Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 9, 178–187, 1999.
   PubMed Web of Science ®Google Scholar
• Kristal AR, Brasky TM, Lampe JE, Patterson RE, and White E: Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort. Manuscript under review.
   Google Scholar
• Kato I, Majumdar AP, Land SJ, Barnholtz-Sloan JS, and Severson RK: Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer 127, 942–951, 2010.
   PubMed Web of Science ®Google Scholar
• He J, Wilkens LR, Stram DO, Kolonel LN, Henderson BE, et al.: Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations. Cancer Epidemiol Biomarkers Prev 20, 70–81, 2011.
   PubMed Web of Science ®Google Scholar
• Houlston RS, Cheadle J, Dobbins SE, Tenesa A, Jones AM, et al.: Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 42, 973–977, 2010.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Lundgreen A, Herrick JS, Wolff RK, and Caan BJ: Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer 117, 4175–4183, 2011.
   PubMed Web of Science ®Google Scholar
• Lubbe SJ, Whiffin N, Chandler I, Broderick P, and Houlston RS: Relationship between 16 susceptibility loci and colorectal cancer phenotype in 3146 patients. Carcinogenesis 33, 108–112, 2012.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Kumlin M, Ingelman-Sundberg M, and Wolk A: Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79, 935–945, 2004.
   PubMed Web of Science ®Google Scholar
• Theodoratou E, McNeill G, Cetnarskyj R, Farrington SM, Tenesa A, et al.: Dietary fatty acids and colorectal cancer: a case-control study. Am J Epidemiol 166, 181–195, 2007.
   PubMed Web of Science ®Google Scholar
• Hall MN, Campos H, Li H, Sesso HD, Stampfer MJ, et al.: Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16, 314–321, 2007.
   PubMed Web of Science ®Google Scholar
• Kojima M, Wakai K, Tokudome S, Suzuki K, Tamakoshi K, et al.: Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: a prospective study. Am J Epidemiol 161, 462–471, 2005.
   PubMed Web of Science ®Google Scholar
• Sasazuki S, Inoue M, Iwasaki M, Sawada N, Shimazu T, et al. Intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan public health center-based prospective study. Int J Cancer 129, 1718–1729, 2011.
   PubMed Web of Science ®Google Scholar
• Butler LM, Wang R, Koh WP, Stern MC, Yuan JM, et al.: Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int J Cancer 124, 678–686, 2009.
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, et al.: Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376, 1741–1750, 2010.
   PubMed Web of Science ®Google Scholar
• Botma A, Nagengast FM, Braem MG, Hendriks JC, Kleibeuker JH, et al.: Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. J Clin Oncol 28, 4346–4353, 2010.
   PubMed Web of Science ®Google Scholar
• Heine-Bröring RC, Winkels RM, Botma A, van Duijnhoven FJB, Jung AY, et al.: Dietary supplement use and colorectal adenoma risk in individuals with Lynch Syndrome: The GEOLynch Cohort Study. PloS ONE 8, e66819, 2013.
   PubMed Web of Science ®Google Scholar
• Stern MC, Butler LM, Corral R, Joshi AD, Yuan JM, et al.: Polyunsaturated fatty acids, DNA repair single nucleotide polymorphisms and colorectal cancer in the Singapore Chinese Health Study. J Nutrigenet Nutrigenomics 2, 273–279, 2009.
   PubMed Web of Science ®Google Scholar
• Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, et al.: PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes Nutr 8, 115–126, 2012.
   PubMed Web of Science ®Google Scholar
• Poole EM, Bigler J, Whitton J, Sibert JG, Kulmacz RJ, et al.: Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps. Carcinogenesis 28, 1259–1263, 2007.
   PubMed Web of Science ®Google Scholar
• Mollard RC, Gillam ME, Wood TM, Taylor CG, and Weiler HA: (n-3) fatty acids reduce the release of prostaglandin E2 from bone but do not affect bone mass in obese (fa/fa) and lean Zucker rats. J Nutr 135, 499–504, 2005.
   PubMed Web of Science ®Google Scholar
• Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, et al.: Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19–30, 2006.
   PubMed Web of Science ®Google Scholar
• Fritsche K: Fatty acids as modulators of the immune response. Annu Rev Nutr 26, 45–73, 2006.
   PubMed Web of Science ®Google Scholar
• Kantor ED, Lampe JW, Vaughan TL, Peters U, Rehm CD, et al.: Association between use of specialty dietary supplements and C-reactive protein concentrations. American Journal of Epidemiology 176, 1002–1013, 2012.
   PubMed Web of Science ®Google Scholar
• Chapkin RS, Kim W, Lupton JR, and McMurray DN: Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 81, 187–191, 2009.
   PubMed Web of Science ®Google Scholar
• Wall R, Ross RP, Fitzgerald GF, and Stanton C: Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68, 280–289, 2010.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Joshi-Barve S, Barve S, and Chen LH: Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23, 71–78, 2004.
   PubMed Web of Science ®Google Scholar
• Li Q, Withoff S, and Verma IM: Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol 26, 318–325, 2005.
   PubMed Web of Science ®Google Scholar
• Chang WL, Chapkin RS, and Lupton JR: Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J Nutr 128, 491–497, 1998.
   PubMed Web of Science ®Google Scholar